Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response.
Atasayar G, Eryilmaz IE, Karli N, Egeli U, Zarifoglu M, Cecener G, Taskapilioglu O, Tunca B, Yildirim O, Ak S, Tezcan G, Can FE.
Atasayar G, et al. Among authors: taskapilioglu o.
J Neurol Sci. 2016 Jul 15;366:149-154. doi: 10.1016/j.jns.2016.05.019. Epub 2016 May 13.
J Neurol Sci. 2016.
PMID: 27288795